Abstract
Alginate sulfate (AS) and its ***quaterized derivatives (QAS-1, QAS-2, and QAS-3) were prepared from sodium alginate. Their structure was characterized by elemental analysis, FT-IR, 13C NMR, and gel permeation chromatography. The in vitro coagulation assay of human plasma containing the sulfates indicated that AS had considerably high anticoagulant activity especially to the intrinsic coagulation pathway. Its APTT reached 226s at 16.7μg/ml, comparing to that of heparin 125s at 10μg/ml. After quaterization the anticoagulant activities of QAS-1, QAS-2, and QAS-3 decreased as the degree of substitution of quaterization increased. The lowest one was given by QAS-3, which gave APTT as 260s at 66.7μg/ml, while AS did as 24min at the same concentration. It could be concluded that AS could be used as a novel anticoagulant drug, and its quaterized derivatives, which contained a great many of sulfate groups but low anticoagulant activity, might have potential application in other field such as anti-HIV.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
